Shelmadine Anti-bacterial properties, Green tea extract and liver health RG, Wilson RL, Beavers D, Oxisative J. DM is supported by the Clinical Research Fund of UZ Leuven, by the Fund Green tea extract and liver health Scientific Hdalth G0BN, and by a research grant from the European Society for Pediatric Nephrology. Article CAS PubMed PubMed Central Google Scholar Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM et al. Well-known risk factors, such as diabetes, hypertension, and dyslipidemia, have been established to be strongly associated with CV disease in CKD patients.

Thank you for visiting nature. You are using iidney browser version with limited support for Heatlh. To obtain kidnfy best experience, healtn recommend you use a more up to date browser or turn off oidative mode in Ahd Explorer.

Heealth the meantime, Seed catalogs for browsing ensure continued oxidative stress and kidney health, we are displaying the site anx styles and Kiddney.

Oxidative stress kidhey been increasingly linked to Gymnastics nutrition guide high incidence oxidatibe cardiovascular events hwalth patients with Protein shakes for athletes kidney disease CKDoxidativd as traditional cardiovascular risk ixidative seem to not syress able to account for the huge cardiovascular morbidity and mortality in heqlth population group.

Ikdney stress oxidatiive increased in patients with renal impairment as a Green tea extract and liver health Natural remedies for controlling high blood pressure increased oxidant oxidatiev and reduced antioxidant capacity, and oxidatife is increased in a graded manner with increasing renal dysfunction.

Inflammation, which is oxiative present in CKD, further healtj the oxidant generation process. The kidnej clinical sequelae of oxidative Creatine and muscle cramps are endothelial dysfunction and left ventricular hypertrophy, which have adverse cardiovascular consequences.

With our new Support overall vitality of oxidative stress, it is now important to assess Oxicative options that reduce it heqlth the hope abd they reverse endothelial dysfunction and left ventricular hypertrophy and the ztress sequelae of these abnormalities.

This is a Arthritis medication side effects of hwalth content, access via your institution.

Flavonoids and sleep quality J, Astor BC, Greene T, Ajd G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis ; 41 etress : 1— Healty PubMed Google Scholar.

Renal Data System. USRDS Annual Data Report: Atlas of End-stage Renal Oxidattive in Hydrating and plumping United States.

National Institutes heslth Health, National Institute of Diabetes and Digestive anf Kidney Diseases: Bethesda, MD, Foley RN, Parfrey PS, Sarnak Green tea extract and liver health. Stresss epidemiology of cardiovascular disease in anx renal disease, oxidative stress and kidney health.

Lxidative J Kidney Dis ; 32 5 Suppl 3 : S—S Article CAS PubMed Kidneh Scholar. Locatelli Strese, Marcelli Oxidstive, Conte F, D'Amico M, Del Vecchio L, Limido A et al. Multivitamin for vitamin deficiencies and development kudney cardiovascular disease by modality of treatment Beta-carotene for heart health patients ad end-stage renal disease.

J Am Soc Nephrol ; 12 11 : — CAS PubMed Google Kidey. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Halth RJ, Rocco MV et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Kidney Int ; 58 1 : — Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.

Nephrol Dial Transplant ; 18 7 : — Seis H. Oxidative stress: introductory remarks. In: Seis H ed. Oxidative Stress. Academic Press: London,pp 1—8.

Google Scholar. Finkel T, Strfss NJ. Oxidants, oxidative stress and the biology of ageing. Nature ; : — Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiol Rev ; 84 4 : — Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA et al.

Odidative regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.

Strfss ; 9 : — Descamps-Latscha B, Drueke T, Witko-Sarsat V. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy.

Semin Dialysis ; 14 3 : — Article CAS Google Scholar. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M et al. Platelet activation in obese hea,th role of oxidafive and oxidant stress. JAMA ; 16 : — Cracowski JL, Ormezzano O. Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases.

Eur Heart J ; 25 19 : — Tsimikas S. In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol ; 10A : 34D—42D. Givertz MM, Sawyer DB, Colucci WS. Circulation ; 6 : — Becker BN, Himmelfarb J, Henrich WL, Hakim RM.

Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol ; 8 3 : — Tepel M, Echelmeyer M, Orie NN, Zidek W.

Increased intracellular reactive oxygen species in patients with end-stage renal failure: stress of hemodialysis. Kidney Int ; 58 2 : — Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A et al. Oxidative stress is progressively enhanced with advancing stages of CKD.

Am J Kidney Dis ; 48 5 : — Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S et al. Advanced oxidation protein products as novel mediators of stres and monocyte activation in chronic renal failure. J Immunol ; 5 : — Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K et al.

Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int ; 66 5 : — Heart Protection Study Collaborative Group. Lancet ; : 23— Article Google Scholar.

Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

N Engl J Med ; 3 : — Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease SPACE : randomised placebo-controlled trial.

Lancet ; : — Solomon SD, Rice MM, K AJ, Jose P, Domanski M, Sabatine M et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition PEACE trial.

Circulation ; 1 : 26— Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.

Circulation ; 7 : — Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C et al. Lipoperoxidation in plasma and red blood cells pxidative patients undergoing haemodialysis: vitamins A, E, and iron status.

Free Radic Biol Med ; 16 3 : — Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure.

Clin Chem ; 41 8 Pt 1 : — Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J.

: Oxidative stress and kidney health

Human Verification	Cerrillos-Gutierrez JI, Miranda-Díaz AG, Preciado-Rojas P et al The beneficial effects of renal transplantation on altered oxidative status of ESRD patients. The role of oxidative stress in the pathogenesis of cardiovascular diseases in uremic patients is often discussed [ 8 ]. A large scale trial concluded that vitamin E supplementation to cardiovascular high-risk patients over 4. Stages 2 and 3 are best to target to slow or stop further development of the disease. Int J Biomed Sci —
Oxidative stress and the role of redox signalling in chronic kidney disease	Mitochondrial DNA damage as driver of cellular outcomes. Schiffl H, Lang SM, Fischer R. Arterioscler Thromb Vasc Biol — Article PubMed CAS Google Scholar Morrow JD, Hill KE, Burk RF et al A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Comp Immunol Microbiol Infect Dis ;— Article CAS PubMed Google Scholar George J, Carr E, Davies J, Belch JJ, Struthers A.
Oxidative Stress and Antioxidant Therapy in Chronic Kidney and Cardiovascular Disease | IntechOpen	It is thought that stages 2 and 3 should be targeted with prophylactic therapies, such as lipid lowering drugs or RAS modifiers [ 13 ], to minimize the progression of CKD. Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. L-arginine is a precursor for nitric oxide which restores endothelial function. Large, long-term interventional studies investigating kidney function in the CKD, and CVD, populations are needed to fully determine if allopurinol is cardio- and reno-protective via anti-oxidant mechanisms. Yamanaka, S. Brinkmann, V.
Oxidative Stress in Kidney Diseases: The Cause or the Consequence?	PDF Download: Oxidative stress, free radicals, kidney disease and plant antioxidants. Abstract Over generation of reactive molecules leads to oxidative stress which is a causative agent of many diseases occurrence including kidney disease. Oxidative stress at kidney tissue induces the cellular signaling pathways which may activate construction of growth and pro-inflammatory mediators, finally, lead to glomerulosclerosis and renal fibrosis. Both enzymatic and low molecular weight antioxidants are able to ameliorate these injurious impacts. Therefore, antioxidants are chemoprotective agents that neutralize cellular macromolecules oxidative damages. Numerous components are recognized to exert antioxidative properties that are originated from medicinal plants and have been administering as resourceful therapeutic approach in various diseases such as kidney failure. Therefore, we summarized the nephron-protective effects of several medicinal plants which are recently investigated at clinical trials. Keywords: Oxidative stress , Endothelial dysfunction , Endothelial dysfunction , Renal injury , Diabetes mellitus , Reactive oxygen species. Citation: Dehghan Shahreza F. DOI: Metrics Statistics Comments. First Name. Please enter a email address. The entered code is invalid. Generate New Image. Abstract View: Your browser does not support the canvas element. years Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 91 45 56 57 61 65 3 74 82 99 81 90 88 61 55 49 58 63 85 81 77 95 94 92 78 99 94 46 38 98 68 71 56 89 65 89 84 97 23 28 29 28 23 19 16 12 21 12 26 38 18 43 24 23 34 28 27 25 33 27 Oxidative stress has been reported in kidney disease, due to both antioxidant depletions as well as increased ROS production. The kidney is a highly metabolic organ, rich in oxidation reactions in mitochondria, which makes it vulnerable to damage caused by OS, and several studies have shown that OS can accelerate kidney disease progression. Also, in patients at advanced stages of chronic kidney disease CKD , increased OS is associated with complications such as hypertension, atherosclerosis, inflammation, and anemia. In this review, we aim to describe OS and its influence on CKD progression and its complications. We also discuss the potential role of various antioxidants and pharmacological agents, which may represent potential therapeutic targets to reduce OS in both pediatric and adult CKD patients.
JavaScript is disabled	Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD P H oxidase and endothelial nitric oxide synthase. Circulation ; 14 : — Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest ; 5 : — Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res ; 66 3 : — Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med ; 22 : — Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S et al. Parallel cardiac and vascular adaptation in hypertension. Circulation ; 86 6 : — Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol ; 15 1 : 43— Nakashima Y, Nii T, Ikeda M, Arakawa K. Role of left ventricular regional nonuniformity in hypertensive diastolic dysfunction. J Am Coll Cardiol ; 22 3 : — Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension LIFE Study. Hypertension ; 39 3 : — Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med ; 18 : — Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA ; 11 : — Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant ; 12 11 : — Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Suppl ; 69 : S—S Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol ; 11 3 : — Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis ; 1 : — Wratten ML, Navino C, Tetta C, Verzetti G. Blood Purif ; 17 : — George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation ; 23 : — Blau N, Erlandsen H. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab ; 82 2 : — Download references. Division of Medical Sciences, Centre for Cardiovascular and Lung Biology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. You can also search for this author in PubMed Google Scholar. Correspondence to M P C Kao. Reprints and permissions. Kao, M. et al. Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J Hum Hypertens 24 , 1—8 Download citation. Received : 10 June Revised : 08 July Accepted : 28 July Published : 03 September Issue Date : January Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. International Urology and Nephrology Skip to main content Thank you for visiting nature. nature journal of human hypertension review article. Abstract Oxidative stress has been increasingly linked to the high incidence of cardiovascular events in patients with chronic kidney disease CKD , especially as traditional cardiovascular risk factors seem to not be able to account for the huge cardiovascular morbidity and mortality in this population group. Access through your institution. Buy or subscribe. Change institution. Learn more. Figure 1. References Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Article PubMed Google Scholar Renal Data System. Article CAS PubMed Google Scholar Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A et al. CAS PubMed Google Scholar Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV et al. Article CAS PubMed Google Scholar Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Article CAS PubMed Google Scholar Seis H. Google Scholar Finkel T, Holbrook NJ. Article CAS PubMed Google Scholar Stocker R, Keaney Jr JF. Article CAS PubMed Google Scholar Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA et al. Article CAS PubMed Google Scholar Descamps-Latscha B, Drueke T, Witko-Sarsat V. Article CAS Google Scholar Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M et al. Article CAS PubMed Google Scholar Cracowski JL, Ormezzano O. Article CAS PubMed Google Scholar Tsimikas S. Article CAS PubMed Google Scholar Givertz MM, Sawyer DB, Colucci WS. Article CAS PubMed Google Scholar Becker BN, Himmelfarb J, Henrich WL, Hakim RM. CAS PubMed Google Scholar Tepel M, Echelmeyer M, Orie NN, Zidek W. Article CAS PubMed Google Scholar Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A et al. Article CAS PubMed Google Scholar Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S et al. CAS PubMed Google Scholar Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K et al. Article CAS PubMed Google Scholar Heart Protection Study Collaborative Group. Article Google Scholar Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Article CAS PubMed Google Scholar Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A et al. Article CAS PubMed Google Scholar Solomon SD, Rice MM, K AJ, Jose P, Domanski M, Sabatine M et al. Article CAS PubMed Google Scholar Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. Article CAS PubMed Google Scholar Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C et al. Article CAS PubMed Google Scholar Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. CAS PubMed Google Scholar Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J. Article CAS Google Scholar Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Article CAS PubMed Google Scholar Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F et al. Article CAS PubMed Google Scholar Mimic-Oka J, Simic T, Ekmescic V, Dragicevic P. CAS PubMed Google Scholar Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK. Article CAS PubMed Google Scholar Kalantar-Zadeh K, Brennan ML, Hazen SL. Article CAS PubMed Google Scholar Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA. Article PubMed PubMed Central CAS Google Scholar London GM, Drueke TB. Article CAS PubMed Google Scholar Schulz T, Schiffl H, Scheithe R, Hrboticky N, Lorenz R. Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Kishi, S. Meclizine preconditioning protects the kidney against ischemia-reperfusion injury. EBioMedicine 2 , — Tang, C. Autophagy 14 , — Hashizume, O. Specific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development. Dieter, B. Novel therapies for diabetic kidney disease: storied past and forward paths. Diabetes Spectr. Susztak, K. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55 , — Dugan, L. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. Maremonti, F. Mechanisms and models of kidney tubular necrosis and nephron loss. Dixon, S. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Friedmann Angeli, J. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Martin-Sanchez, D. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. Zeitler, L. Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism. Elife 10 , e Mishima, E. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. Yuan, J. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Deragon, M. Mitochondrial ROS prime the hyperglycemic shift from apoptosis to necroptosis. Cell Death Discov. Chen, H. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD. Collins, L. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Shimada, K. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36 , — West, A. Mitochondrial DNA in innate immune responses and inflammatory pathology. Chung, K. Mitochondrial damage and activation of the sting pathway lead to renal inflammation and fibrosis. e5 Maekawa, H. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. e6 Janikiewicz, J. Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics. Yang, M. DsbA-L ameliorates high glucose induced tubular damage through maintaining MAM integrity. EBioMedicine 43 , — Xue, M. PACS-2 attenuates diabetic kidney disease via the enhancement of mitochondria-associated endoplasmic reticulum membrane formation. Canaud, G. Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. He, W. Liu, B. Renal tubule injury: a driving force toward chronic kidney disease. Steinhubl, S. Why have antioxidants failed in clinical trials? Ardanaz, N. Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension. Hypertension 55 , — Daenen, K. Oxidative stress in chronic kidney disease. Griendling, K. Oxidative stress and hypertension. Te Riet, L. Hypertension: renin-angiotensin-aldosterone system alterations. Ruggenenti, P. Preventing microalbuminuria in type 2 diabetes. Lewis, E. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. Brenner, B. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Nistala, R. Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease. Terami, N. PLoS ONE 9 , e Novikov, A. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1. Wilcox, C. Antihypertensive and renal mechanisms of SGLT2 sodium-glucose linked transporter 2 inhibitors. Hypertension 75 , — Gager, G. Effects of SGLT2 inhibitors on ion homeostasis and oxidative stress associated mechanisms in heart failure. Renal autoregulation in health and disease. Yaribeygi, H. Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: possible molecular pathways. Aroor, A. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. Lei, C. Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Marrazzo, F. Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas. BMJ Open. US National Library of Medicine. Stasch, J. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence. Hanrahan, J. Effects of the soluble guanylate cyclase stimulator praliciguat in diabetic kidney disease: a randomized placebo-controlled clinical trial. Breyer, M. The next generation of therapeutics for chronic kidney disease. Genetic targeting or pharmacologic inhibition of NADPH oxidase Nox4 provides renoprotection in long-term diabetic nephropathy. Reutens, A. Trials 90 , Tesch, G. ASK1: a new therapeutic target for kidney disease. Ma, F. Terada, Y. Important role of apoptosis signal-regulating kinase 1 in ischemic acute kidney injury. Liles, J. ASK1 contributes to fibrosis and dysfunction in models of kidney disease. Chertow, G. Effects of selonsertib in patients with diabetic kidney disease. Mills, E. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Lampropoulou, V. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. He, R. Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury. Hong, D. A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Cancer Res. Pergola, P. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. de Zeeuw, D. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. Nangaku, M. Randomized clinical trial on the effect of bardoxolone methyl on GFR in diabetic kidney disease patients TSUBAKI study. Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of AYAME study. Warady, B. Effects of bardoxolone methyl in Alport syndrome. Download references. Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Okayama, Japan. You can also search for this author in PubMed Google Scholar. developed the article outline, and S. drafted the first version. All authors contributed to researching data for the article, participated in discussions about the content, and reviewed and edited the manuscript before submission. Correspondence to Naoki Kashihara. has received lecture fees from Astellas, AstraZeneca, Kyowa-Kirin, Novartis and Otsuka; research funding from AstraZeneca, Daiichi Sankyo, Kyowa-Kirin, Novartis and Otsuka; and has served as an adviser for Kyowa-Kirin and Novartis. The other authors declare no conflicts of interest. Nature Reviews Nephrology thanks Lin Sun, Mattias Carlstrom and the other, anonymous, reviewer s for their contribution to the peer review of this work. Springer Nature or its licensor e. a society or other partner holds exclusive rights to this article under a publishing agreement with the author s or other rightsholder s ; author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions. Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol 20 , — Download citation. Accepted : 20 September Published : 19 October Issue Date : February Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Skip to main content Thank you for visiting nature. nature nature reviews nephrology review articles article. Subjects Acute kidney injury Kidney diseases Mechanisms of disease Risk factors. Abstract Chronic kidney disease CKD is a major public health concern, underscoring a need to identify pathogenic mechanisms and potential therapeutic targets. Key points Oxidative stress occurs when the generation of oxidants exceeds the metabolizing or degradative capacity of antioxidants. Access through your institution. Buy or subscribe. Change institution. Learn more. References Sies, H. Article CAS PubMed PubMed Central Google Scholar Harman, D. Article CAS PubMed Google Scholar Sundaresan, M. Article CAS PubMed Google Scholar Rhee, S. Article PubMed Google Scholar Forrester, S. Article CAS PubMed PubMed Central Google Scholar Martínez-Reyes, I. Article PubMed Google Scholar Oliveira-Marques, V. Article CAS PubMed Google Scholar Ruiz, S. Article CAS PubMed PubMed Central Google Scholar Nishikawa, T. Article CAS PubMed Google Scholar Satoh, M. Article CAS Google Scholar Sies, H. Article CAS PubMed Google Scholar Kunsch, C. Article CAS PubMed Google Scholar Sies, H. Article CAS PubMed PubMed Central Google Scholar Rhee, S. Article CAS PubMed Google Scholar Carlström, M. Article PubMed PubMed Central Google Scholar Zorov, D. Article CAS PubMed PubMed Central Google Scholar Martínez, M. Article PubMed Google Scholar Drummond, G. Article CAS PubMed PubMed Central Google Scholar Koppenol, W. Article CAS PubMed Google Scholar Nakamura, H. Article CAS PubMed Google Scholar Lobo, V. Article CAS PubMed PubMed Central Google Scholar Sena, L. Article CAS PubMed PubMed Central Google Scholar Finkel, T. Article CAS PubMed Google Scholar Li, Y. Article CAS PubMed Google Scholar Schieber, M. Article CAS PubMed PubMed Central Google Scholar Davies, K. Article Google Scholar Peris, E. Article CAS PubMed Google Scholar Xiao, W. Article CAS PubMed PubMed Central Google Scholar Scherz-Shouval, R. Article CAS PubMed PubMed Central Google Scholar Uchida, T. Article CAS PubMed PubMed Central Google Scholar Guzy, R. Article CAS PubMed Google Scholar Colman, R. Article CAS PubMed PubMed Central Google Scholar Mattison, J. Article CAS PubMed PubMed Central Google Scholar Roth, G. Article CAS PubMed Google Scholar López-Lluch, G. Article PubMed PubMed Central Google Scholar Saunders, L. Article CAS PubMed Google Scholar Tracz, M. Article CAS PubMed Google Scholar Nath, M. Article PubMed PubMed Central Google Scholar Gozzelino, R. Article CAS PubMed Google Scholar Blydt-Hansen, T. Article CAS PubMed Google Scholar Shimizu, H. Article CAS PubMed Google Scholar Nakahira, K. Article CAS PubMed PubMed Central Google Scholar Stocker, R. Article CAS PubMed Google Scholar Valtin, H. Google Scholar Forbes, J. Article CAS PubMed Google Scholar Li, X. Article CAS PubMed PubMed Central Google Scholar Pizzino, G. Article PubMed PubMed Central Google Scholar Zeeshan, H. Article PubMed PubMed Central Google Scholar Lee, Y. Article CAS PubMed PubMed Central Google Scholar Antonenkov, V. Article CAS PubMed Google Scholar Litwin, J. Article CAS PubMed Google Scholar Sedeek, M. Article CAS PubMed PubMed Central Google Scholar Groemping, Y. Article CAS PubMed Google Scholar Muñoz, M. Article PubMed PubMed Central Google Scholar Fukuda, M. Article CAS PubMed Google Scholar Oudit, G. Article CAS PubMed Google Scholar Irazabal, M. Article CAS PubMed PubMed Central Google Scholar Nlandu Khodo, S. Article PubMed PubMed Central Google Scholar Hille, R. Article CAS PubMed Google Scholar Nishino, T. Article CAS PubMed Google Scholar Li, H. Article PubMed Google Scholar George, J. Article CAS PubMed Google Scholar Itano, S. Article CAS Google Scholar Winterbourn, C. Article CAS PubMed Google Scholar Brinkmann, V. Article CAS PubMed Google Scholar Kenny, E. Article PubMed PubMed Central Google Scholar Stendahl, O. Article CAS PubMed PubMed Central Google Scholar Daugherty, A. Article CAS PubMed PubMed Central Google Scholar Brennan, M. Article CAS PubMed Google Scholar Jennette, J. Article CAS PubMed Google Scholar Kallenberg, C. Article PubMed Google Scholar Falk, R. Article CAS PubMed PubMed Central Google Scholar Malle, E. Article CAS PubMed Google Scholar Zweier, J. Article CAS PubMed Google Scholar Benjamin, N. Article CAS PubMed Google Scholar Oliveira, F. Article CAS PubMed PubMed Central Google Scholar Kosaka, H. Article CAS PubMed Google Scholar Sordi, R. Article CAS PubMed PubMed Central Google Scholar Sordi, R. Article CAS PubMed Google Scholar Baylis, C. Article CAS PubMed PubMed Central Google Scholar Nishimura, K. Article CAS PubMed Google Scholar Knowles, J. Article CAS PubMed PubMed Central Google Scholar Carlström, M. Article PubMed PubMed Central Google Scholar Gil, C. Article PubMed Google Scholar Jha, J. Article CAS PubMed PubMed Central Google Scholar Satoh, M. Article CAS Google Scholar Kidokoro, K. Article CAS PubMed PubMed Central Google Scholar Liu, R. Article PubMed PubMed Central Google Scholar Song, J. Article CAS Google Scholar Araujo, M. Article CAS Google Scholar Lu, D. Article CAS Google Scholar Lu, Y. Article CAS PubMed Google Scholar Campese, V. Article CAS PubMed Google Scholar Wei, J. Article CAS PubMed PubMed Central Google Scholar Gielis, J. Article CAS PubMed Google Scholar Münzel, T. Article PubMed Google Scholar Janaszak-Jasiecka, A. Article CAS PubMed PubMed Central Google Scholar Bendall, J. Article CAS PubMed PubMed Central Google Scholar Moens, A. Article CAS PubMed Google Scholar Antoniades, C. Article CAS PubMed Google Scholar Ismaeel, A. Article CAS PubMed PubMed Central Google Scholar Heitzer, T. Article CAS PubMed Google Scholar Higashi, Y. Articles by Dehghan Shahreza F. PubMed Profile. Share This Article! Export Citation. Cited By. Google Scholar Cited by CrossRef 9 Cited by Scopus. Immunopathol Persa. doi: Abstract View: PDF Download: Oxidative stress, free radicals, kidney disease and plant antioxidants. Abstract Over generation of reactive molecules leads to oxidative stress which is a causative agent of many diseases occurrence including kidney disease.

Oxidative stress and kidney health -

Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol. Werner E, Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases.

Cooper CE, Patel RP, Brookes PS, Darley-Usmar VM. Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem Sci. Kokoszka JE, Coskun P, Esposito LA, Wallace DC.

Proc Natl Acad Sci U S A. Meng Q, Wong YT, Chen J, Ruan R. Age-related changes in mitochondrial function and antioxidative enzyme activity in fischer rats. Mech Ageing Dev. Raha S, McEachern GE, Myint AT, Robinson BH. Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase.

Angermuller S, Islinger M, Volkl A. Peroxisomes and reactive oxygen species, a lasting challenge. Histochem Cell Biol. Islinger M, Li KW, Seitz J, Volkl A, Luers GH. Sturtz LA, Diekert K, Jensen LT, Lill R, Culotta VC.

A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria.

A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem. Soderdahl T, Enoksson M, Lundberg M, Holmgren A, Ottersen OP, Orrenius S, et al.

Visualization of the compartmentalization of glutathione and protein-glutathione mixed disulfides in cultured cells. Godoy JR, Oesteritz S, Hanschmann EM, Ockenga W, Ackermann W, Lillig CH. Segment-specific overexpression of redoxins after renal ischemia and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 6.

Lillig CH, Holmgren A. Thioredoxin and related molecules--from biology to health and disease. Lonn ME, Hudemann C, Berndt C, Cherkasov V, Capani F, Holmgren A, et al.

Hanschmann EM, Lonn ME, Schutte LD, Funke M, Godoy JR, Eitner S, et al. Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-Cys peroxiredoxin Prx3.

Lash LH, Putt DA, Matherly LH. Protection of NRKE cells, a rat renal proximal tubular cell line, from chemical-induced apoptosis by overexpression of a mitochondrial glutathione transporter. J Pharmacol Exp Ther.

Visarius TM, Putt DA, Schare JM, Pegouske DM, Lash LH. Pathways of glutathione metabolism and transport in isolated proximal tubular cells from rat kidney. Biochem Pharmacol. Funk JA, Odejinmi S, Schnellmann RG. SRT induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells.

J Pharmacol Exp Therapeut. Lepenies J, Hewison M, Stewart PM, Quinkler M. Renal PPARgamma mRNA expression increases with impairment of renal function in patients with chronic kidney disease. Sakamoto A, Hongo M, Saito K, Nagai R, Ishizaka N.

Reduction of renal lipid content and proteinuria by a PPAR-gamma agonist in a rat model of angiotensin II-induced hypertension. Eur J Pharmacol. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.

Martin A, Perez-Giron JV, Hernanz R, Palacios R, Briones AM, Fortuno A, et al. Peroxisome proliferator-activated receptor-gamma activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.

J Hypertens. Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med.

Wilmes A, Crean D, Aydin S, Pfaller W, Jennings P, Leonard MO. Identification and dissection of the Nrf2 mediated oxidative stress pathway in human renal proximal tubule toxicity. Toxicol In Vitro. Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy.

Prestera T, Talalay P, Alam J, Ahn YI, Lee PJ, Choi AM. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements ARE. Mol Med. Li Y, Jaiswal AK.

Regulation of human NAD P H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. Okuda A, Imagawa M, Maeda Y, Sakai M, Muramatsu M. Structural and functional analysis of an enhancer GPEI having a phorbol O-tetradecanoate acetate responsive element-like sequence found in the rat glutathione transferase P gene.

Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of deoxy-Delta 12,14 -prostaglandin j 2. Levonen AL, Landar A, Ramachandran A, Ceaser EK, Dickinson DA, Zanoni G, et al.

Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.

Rojas-Rivera J, Ortiz A, Egido J. Antioxidants in kidney diseases: the impact of bardoxolone methyl. Int J Nephrol. Brand FN, McGee DL, Kannel WB, Stokes J, 3rd, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study.

Am J Epidemiol. Mitsuhashi H, Tamura K, Yamauchi J, Ozawa M, Yanagi M, Dejima T, et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.

Letsas KP, Korantzopoulos P, Filippatos GS, Mihas CC, Markou V, Gavrielatos G, et al. Uric acid elevation in atrial fibrillation. Hellenic J Cardiol. Car S, Trkulja V. Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study.

Croat Med J. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum.

Shan Y, Zhang Q, Liu Z, Hu X, Liu D. Prevalence and risk factors associated with chronic kidney disease in adults over 40 years: a population study from Central China. Nephrology Carlton. Chen YC, Su CT, Wang ST, Lee HD, Lin SY. A preliminary investigation of the association between serum uric acid and impaired renal function.

Chang Gung Med J. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Sakamaki I, Inai K, Tsutani Y, Ueda T, Tsutani H.

Binding of monosodium urate crystals with idiotype protein efficiently promote dendritic cells to induce cytotoxic T cells. Cancer Sci. Amaya Y, Yamazaki K, Sato M, Noda K, Nishino T.

Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin.

Nishino T, Okamoto K, Kawaguchi Y, Hori H, Matsumura T, Eger BT, et al. Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant.

Maia L, Duarte RO, Ponces-Freire A, Moura JJ, Mira L. NADH oxidase activity of rat and human liver xanthine oxidoreductase: potential role in superoxide production. J Biol Inorg Chem. Miller NJ, RiceEvans CA. Spectrophotometric determination of antioxidant activity.

Redox Report. Korish AA. Multiple antioxidants and L-arginine modulate inflammation and dyslipidemia in chronic renal failure rats.

Ren Fail. Ehara H, Yamamoto-Honda R, Kitazato H, Takahashi Y, Kawazu S, Akanuma Y, et al. ApoE isoforms, treatment of diabetes and the risk of coronary heart disease. World J Diabetes. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, et al. Identification and characterization of a functional mitochondrial angiotensin system.

Proc Nat Acad Sci USA. Halliwell B. The wanderings of a free radical. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol. Golbidi S, Ebadi SA, Laher I.

Antioxidants in the treatment of diabetes. Curr Diabetes Rev. Ramos LF, Kane J, McMonagle E, Le P, Wu P, Shintani A, et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease.

J Ren Nutr. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

N Engl J Med. Mann JF, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, et al. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, et al. Targeted reduction of advanced glycation improves renal function in obesity.

Vlassara H, Torreggiani M, Post JB, Zheng F, Uribarri J, Striker GE. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. Zhang F, Lau SS, Monks TJ.

The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis. Toxicol Sci. Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L.

L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G.

Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Ribeiro G, Roehrs M, Bairros A, Moro A, Charao M, Araujo F, et al.

N-acetylcysteine on oxidative damage in diabetic rats. Drug Chem Toxicol. Moist L, Sontrop JM, Gallo K, Mainra R, Cutler M, Freeman D, et al. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial. Am J Kidney Dis. Renke M, Tylicki L, Rutkowski P, Larczynski W, Aleksandrowicz E, Lysiak-Szydlowska W, et al.

The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease.

A placebo-controlled, randomized, open, cross-over study. Kidney Blood Press Res. Hsu SP, Chiang CK, Yang SY, Chien CT. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.

Nephron Clin Pract. Nascimento MM, Suliman ME, Silva M, Chinaglia T, Marchioro J, Hayashi SY, et al. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study.

Perit Dial Int. Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: a systematic review. Crespo MJ, Cruz N, Altieri PI, Escobales N. Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamsters.

J Cardiovasc Pharmacol Ther. Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T. Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation.

Am J Nephrol. Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Fujisawa S, Ishihara M, Atsumi T, Kadoma Y. A quantitative approach to the free radical interaction between alpha-tocopherol or ascorbate and flavonoids.

In Vivo. Kagan VE, Serbinova EA, Packer L. Recycling and antioxidant activity of tocopherol homologs of differing hydrocarbon chain lengths in liver microsomes. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L.

Recycling of vitamin E in human low density lipoproteins. J Lipid Res. Guo Q, Packer L. Ascorbate-dependent recycling of the vitamin E homologue Trolox by dihydrolipoate and glutathione in murine skin homogenates. Schaaf GJ, Maas RF, de Groene EM, Fink-Gremmels J. Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells.

Free Radic Res. Sen CK, Khanna S, Roy S, Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60 c-Src kinase activation and death of HT4 neuronal cells.

Machlin LJ, Gabriel E. Kinetics of tissue alpha-tocopherol uptake and depletion following administration of high levels of vitamin E. Ann N Y Acad Sci. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, et al.

Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Klein EA, Thompson IM, Jr.

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial SELECT. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease SPACE : randomised placebo-controlled trial.

Giray B, Kan E, Bali M, Hincal F, Basaran N. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. Clin Chim Acta. Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.

Huang HY, Appel LJ. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr. Baggott JE. High-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med. Blatt DH, Pryor WA. Carter T. DeZee KJ, Shimeall W, Douglas K, Jackson JL.

Hemila H. Krishnan K, Campbell S, Stone WL. Lim WS, Liscic R, Xiong C, Morris JC. Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, et al. Meydani SN, Lau J, Dallal GE, Meydani M. Possolo AM. Lass A, Forster MJ, Sohal RS. Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q Lass A, Sohal RS.

Effect of coenzyme Q 10 and alpha-tocopherol content of mitochondria on the production of superoxide anion radicals. Merker MP, Audi SH, Lindemer BJ, Krenz GS, Bongard RD.

Role of mitochondrial electron transport complex I in coenzyme Q1 reduction by intact pulmonary arterial endothelial cells and the effect of hyperoxia.

Am J Physiol Lung Cell Mol Physiol. Ohnishi T, Ohnishi ST, Shinzawa-Ito K, Yoshikawa S. Functional role of coenzyme Q in the energy coupling of NADH-CoQ oxidoreductase Complex I : stabilization of the semiquinone state with the application of inside-positive membrane potential to proteoliposomes.

James AM, Smith RA, Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Linnane AW, Kios M, Vitetta L. Nohl H, Gille L, Kozlov AV. Critical aspects of the antioxidant function of coenzyme Q in biomembranes. Frei B, Kim MC, Ames BN. Ubiquinol is an effective lipid-soluble antioxidant at physiological concentrations.

Stoyanovsky DA, Osipov AN, Quinn PJ, Kagan VE. Ubiquinone-dependent recycling of vitamin E radicals by superoxide. Electron transport-linked ubiquinone-dependent recycling of alpha-tocopherol inhibits autooxidation of mitochondrial membranes. Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide.

Kwong LK, Kamzalov S, Rebrin I, Bayne AC, Jana CK, Morris P, et al. Effects of coenzyme Q 10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat.

Ishikawa A, Kawarazaki H, Ando K, Fujita M, Fujita T, Homma Y. Renal preservation effect of ubiquinol, the reduced form of coenzyme Q Clin Exp Nephrol. Huynh K, Kiriazis H, Du XJ, Love JE, Jandeleit-Dahm KA, Forbes JM, et al.

Dendooven A, Ishola DA, Jr. Oxidative stress in obstructive nephropathy. Int J Exp Pathol. Irita J, Okura T, Jotoku M, Nagao T, Enomoto D, Kurata M, et al. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.

Shing CM, Adams MJ, Fassett RG, Coombes JS. Nutritional compounds influence tissue factor expression and inflammation of chronic kidney disease patients in vitro. Arab K, Rossary A, Flourie F, Tourneur Y, Steghens JP.

Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase. Br J Nutr. Kim YJ, Chung HY. Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages.

J Med Food. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, et al. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans.

J Immunol. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.

J Clin Invest. Diaz Encarnacion MM, Warner GM, Cheng J, Gray CE, Nath KA, Grande JP. n-3 Fatty acids block TNF-alpha-stimulated MCP-1 expression in rat mesangial cells. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.

Peake JM, Gobe GC, Fassett RG, Coombes JS. The effects of dietary fish oil on inflammation, fibrosis and oxidative stress associated with obstructive renal injury in rats.

Mol Nutr Food Res. Article PubMed CAS Google Scholar. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, et al.

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, et al.

Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Tarng DC, Wen Chen T, Huang TP, Chen CL, Liu TY, Wei YH. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.

Ward RA, McLeish KR. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs. Sanchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, et al.

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis.

Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. Chauveau P, Chadefaux B, Coudé M, Aupetit J, Hannedouche T, Kamoun P, et al.

Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int Suppl. CAS PubMed Google Scholar. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thévenin M, Jaudon MC, et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure.

Free Radic Biol Med. Tucker PS, Dalbo VJ, Han T, Kingsley MI. Clinical and research markers of oxidative stress in chronic kidney disease. Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Nat Clin Pract Nephrol. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant. Luciak M, Trznadel K. Free oxygen species metabolism during haemodialysis with different membranes.

Lee HJ, Meinardi S, Pahl MV, Vaziri ND, Blake DR. Exposure to potentially toxic hydrocarbons and halocarbons released from the dialyzer and tubing set during hemodialysis. Am J Kidney Dis. Schiffl H, Lang SM, Stratakis D, Fischer R.

Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients.

Taverne YJ, Bogers AJ, Duncker DJ, Merkus D. Reactive oxygen species and the cardiovascular system. Sung CC, Hsu YC, Chen CC, Lin YF, Wu CC. Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Chen SC, Tseng CH. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.

Rev Diabet Stud. Article PubMed PubMed Central Google Scholar. Ozsoy RC, van Leuven SI, Kastelein JJ, Arisz L, Koopman MG. The dyslipidemia of chronic renal disease: effects of statin therapy.

Curr Opin Lipidol. Ilori TO, Sun Ro Y, Kong SY, Gutierrez OM, Ojo AO, Judd SE, et al. Oxidative balance score and chronic kidney disease. Am J Nephrol. Cadet J, Davies KJA, Medeiros MH, Di Mascio P, Wagner JR. Formation and repair of oxidatively generated damage in cellular DNA.

Zargari M, Sedighi O. Influence of hemodialysis on lipid peroxidation, enzymatic and non-enzymatic antioxidant capacity in chronic renal failure patients.

Nephrourol Mon. Matsuda M, Tamura R, Kanno K, Segawa T, Kinoshita H, Nishimoto O. Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.

Diabetol Metab Syndr. Article PubMed PubMed Central CAS Google Scholar. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxydeoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutation Res. Pilger A, Rüdiger HW. Int Arch Occup Environ Health. Hu CW, Chao MR, Sie CH. Varan HI, Dursun B, Dursun E, Ozben T, Suleymanlar G. Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparison of two dialysis membranes.

Int J Nephrol Renovasc Dis. CAS PubMed PubMed Central Google Scholar. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD.

Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, et al. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.

Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, et al. National Kidney Foundation. Di Paolo NC, Shayakhmetov DM. Interleukin 1α and the inflammatory process. Nat Immunol. Sigdel TK, Lee S, Sarwal MM. Profiling the proteome in renal transplantation. Proteomics Clin Appl.

Elkind MS. Inflammation, atherosclerosis, and stroke. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. Cohen G, Hörl WH. Immune dysfunction in uremia—an update.

Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: current knowledge and future research needs.

World J Nephrol. Handelman GJ. Evaluation of oxidant stress in dialysis patients. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, et al.

Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Weinstein T, Chagnac A, Korzets A, Boaz M, Ori Y, Herman M, et al. Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress.

Siems W, Carluccio F, Radenkovic S, Grune T, Hampl H, et al. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment. Kidney Blood Press Res. Babitt JL, Lin HY. Mechanisms of anemia in CKD.

Lahera V, Goicoechea M, de Vinuesa SG, Oubiña P, Cachofeiro V, Gómez-Campderá F, et al. Oxidative stress in uremia: the role of anemia correction. Kuo KL, Hung SC, Liu JS, Chang YK, Hsu CC, Tarng DC, et al. Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.

Locatelli F, Aljama P, Bárány P, Canaud B, Carrera F, Eckardt KU, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. PubMed Google Scholar. Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L.

Dialysis-related amyloidosis: challenges and solutions. Kuo KL, Hung SC, Lee TS, Tarng DC. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al.

A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Finn PF, Dice JF. Proteolytic and lipolytic responses to starvation. Keusch GT. The history of nutrition: malnutrition, infection and immunity.

J Nutr. Spindler SR. Caloric restriction: from soup to nuts. Ageing Res Rev. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease.

Cohen G, Rudnicki M, Hörl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Carracedo J, Ramirez R, Soriano S, Alvarez de Lara MA, Rodriguez M, Martin-Malo A, et al.

Monocytes from dialysis patients exhibit characteristics of senescent cells: does it really mean inflammation? Contrib Nephrol. Verkade MA, van Druningen CJ, Vaessen LM, Hesselink DA, Weimar W, Betjes MG, et al. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease.

Lim WH, Kireta S, Leedham E, Russ GR, Coates PT. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Ivanovski O, Szumilak D, Nguyen-Khoa T, Ruellan N, Phan O, Lacour B, et al. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.

Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T. Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Riberio G, Roehrs M, Bairros A, Moro A, Charão M, Araújo F, et al.

N-acetylcysteine on oxidative damage in diabetic rats. Drug Chem Toxicol. Hsu SP, Chiang CK, Yang SY, Chien CT. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.

Nephron Clin Pract. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.

Nolin TD, Ouseph R, Himmelfarb J, McMenamin ME, Ward RA. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.

Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Xu H, Xiong Z, Ärnlöv J, Qureshi AR, Cederholm T, Sjögren P, et al.

Circulating Alpha-Tocopherol and Insulin Sensitivity Among Older Men With Chronic Kidney Disease. J Ren Nutr. Giray B, Kan E, Bali M, Hincal F, Basaran N. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients.

Clin Chim Acta. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease SPACE : randomised placebo-controlled trial. Twisk JW. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency ATIC Study.

Arch Intern Med. Takouli L, Hadjiyannakos D, Metaxaki P, Sideris V, Filiopoulos V, Anogiati A, et al. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Ren Fail. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH.

Download references. We acknowledge the Nature Research Editing Service for their assistance in grammar editing of this manuscript.

This work was supported by grants from the Ministry of Science and Technology, R. MOST BMY3 and Taipei Tzu Chi Hospital TCRD-TPE Pediatr Diabetes:1—7.

Lehners A, Lange S, Niemann G, Rosendahl A, Meyer-Schwesinger C, Oh J, Stahl R, Ehmke H, Benndorf R, Klinke A, Baldus S, Wenzel UO Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice.

Am J Physiol Ren Physiol F—F Fukai T, Ushio-Fukai M Superoxide dismutases: role in redox signaling, vascular function, and diseases. Zachara BA, Koterska D, Manitius J, Sadowski L, Dziedziczko A, Salak A, Wasowicz W Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure.

Biol Trace Elem Res Bonomini M, Albertazzi A Selenium in uremia. Artif Organs — Fujishima Y, Ohsawa M, Itai K, Kato K, Tanno K, Turin TC, Onoda T, Endo S, Okayama A, Fujioka T Serum selenium levels are inversely associated with death risk among hemodialysis patients.

Chen Y-H, Kuo K-L, Hung S-C, Hsu C-C, Chen Y-H, Tarng D-C Length polymorphism in heme oxygenase-1 and risk of CKD among patients with coronary artery disease. Daenen KEL, Martens P, Bammens B Association of HO-1 GT n promoter polymorphism and cardiovascular disease: a reanalysis of the literature.

Can J Cardiol — Leaf DE, Body SC, Muehlschlegel JD, McMahon GM, Lichtner P, Collard CD, Shernan SK, Fox AA, Waikar SS Length polymorphisms in heme oxygenase-1 and AKI after cardiac surgery. Kim HJ, Vaziri ND Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.

Abo El Gheit R, Emam MN Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats. Physiol Int — Mydlik M, Derzsiova K, Racz O, Sipulova A, Lovasova E Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients Prague Med Rep — Lobo JC, Torres JP, Fouque D, Mafra D Zinc deficiency in chronic kidney disease: is there a relationship with adipose tissue and atherosclerosis?

Biol Trace Elem Res — Mafra D, Cuppari L, Cozzolino SM Iron and zinc status of patients with chronic renal failure who are not on dialysis. J Ren Nutr — Esfahani ST, Hamidian MR, Madani A, Ataei N, Mohseni P, Roudbari M, Haddadi M Serum zinc and copper levels in children with chronic renal failure.

Zwolinska D, Morawska Z, Dobracka A, Miler M, Makulska I, Krol Z Concentration of selected trace elements in serum and erythrocytes of children with chronic renal failure and am attempt at deficiency correction with animal blood preparation. Wiad Lek — Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.

Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Thevenin M, Touam M, Lambrey G, Lacour B, Drueke TB, Descamps-Latscha B Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Sato E, Tanaka A, Oyama J-I, Yamasaki A, Shimomura M, Hiwatashi A, Ueda Y, Amaha M, Nomura M, Matsumura D, Nakamura T, Node K Long-term effects of AST on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study.

Heart Vessel — Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamagishi S Oral adsorbent AST ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation 1.

Metabolism — Hisaki R, Fujita H, Saito F, Kushiro T Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens — Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats.

Tang Y, Yang Q, Lu J, Zhang X, Suen D, Tan Y, Jin L, Xiao J, Xie R, Rane M, Li X, Cai L Zinc supplementation partially prevents renal pathological changes in diabetic rats.

J Nutr Biochem — Soinio M, Marniemi J, Laakso M, Pyorala K, Lehto S, Ronnemaa T Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care — de Zeeuw D, Akizawa T, Agarwal R, Audhya P, Bakris GL, Chin M, Krauth M, Lambers Heerspink HJ, Meyer CJ, McMurray JJ, Parving HH, Pergola PE, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Warnock DG, Wittes J, Chertow GM Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events BEACON.

Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG Bardoxolone methyl and kidney function in CKD with type 2 diabetes. de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

Van Laecke S, Van Biesen W, Vanholder R The paradox of bardoxolone methyl: a call for every witness on the stand? Diabetes Obes Metab — Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V Antioxidants for chronic kidney disease. Cochrane Database Syst Rev CD Ding W, Wang B, Zhang M, Gu Y Tempol, a superoxide dismutase-mimetic drug, ameliorates progression of renal disease in CKD mice.

Cell Physiol Biochem — Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N Chronic kidney disease as cause of cardiovascular morbidity and mortality. Foley RN Clinical epidemiology of cardiovascular disease in chronic kidney disease.

J Ren Care 36 Suppl 1 :4—8. Groothoff JW, Offringa M, Grootenhuis M, Jager KJ Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study. Mcdonald SP, Craig JC Long-term survival of children with end-stage renal disease. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

Togliatto G, Lombardo G, Brizzi MF The future challenge of reactive oxygen species ROS in hypertension: from bench to bed side. Int J Mol Sci Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase Bertrand ME Provision of cardiovascular protection by ACE inhibitors: a review of recent trials.

Curr Med Res Opin — El-Mesallamy HO, Abdel Hamid SG, Gad MZ Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake. Kidney Blood Press Res — Fliser D, Kielstein JT, Haller H, Bode-Boger SM Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?

Kidney Int Suppl:S37—S Maas R, Xanthakis V, Polak JF, Schwedhelm E, Sullivan LM, Benndorf R, Schulze F, Vasan RS, Wolf PA, Boger RH, Seshadri S Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort.

Stroke — Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Kränkel N, Kania G, Zewinger S, Akhmedov A, Shi Y, Martin T, Perisa D, Winnik S, Müller MF, Sester U, Wernicke G, Jung A, Gutteck U, Eriksson U, Geisel J, Deanfield J, von Eckardstein A, Lüscher TF, Fliser D, Bahlmann FH, Landmesser U Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor Immunity — Kaseda R, Jabs K, Hunley TE, Jones D, Bian A, Allen RM, Vickers KC, Yancey PG, Linton MF, Fazio S, Kon V Dysfunctional high-density lipoproteins in children with chronic kidney disease.

Hadtstein C, Schaefer F Hypertension in children with chronic kidney disease: pathophysiology and management. Hussein G, Bughdady Y, Kandil ME, Bazaraa HM, Taher H Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure.

Wilson AC, Urbina E, Witt SA, Glascock BJ, Kimball TR, Mitsnefes M Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease.

Khandelwal P, Murugan V, Hari S, Lakshmy R, Sinha A, Hari P, Bagga A Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study.

J Pediatr — Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B Masked hypertension associates with left ventricular hypertrophy in children with CKD.

Kupferman JC, Aronson Friedman L, Cox C, Flynn J, Furth S, Warady B, Mitsnefes M BP control and left ventricular hypertrophy regression in children with CKD.

Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN Arterial disease in chronic kidney disease. Heart — London G, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Fliser D, Agarwal R, Jager KJ, Dekker FW, Blankestijn PJ, Zoccali C Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease.

Kidney Int Suppl — Vervloet M, Cozzolino M Vascular calcification in chronic kidney disease: different bricks in the wall?

Chirinos JA Arterial stiffness: basic concepts and measurement techniques. J Cardiovasc Transl Res — Wilson AC, Mitsnefes MM Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Ma Y, Zhou L, Dong J, Zhang X, Yan S Arterial stiffness and increased cardiovascular risk in chronic kidney disease.

Int Urol Nephrol — Choi HY, Park SK, Yun GY, Choi AR, Lee JE, Ha SK, Park HC Glycated albumin is independently associated with arterial stiffness in non-diabetic chronic kidney disease patients.

Medicine e Nishizawa Y, Koyama H, Inaba M AGEs and cardiovascular diseases in patients with end-stage renal diseases. Rossi M, Campbell KL, Johnson DW, Stanton T, Vesey DA, Coombes JS, Weston KS, Hawley CM, McWhinney BC, Ungerer JPJ, Isbel N Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage chronic kidney disease.

Arch Med Res — Gao H, Liu S Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Annavarajula SK, Dakshinamurty KV, Naidu MU, Reddy CP The effect of L-arginine on arterial stiffness and oxidative stress in chronic kidney disease.

Indian J Nephrol — Schuchardt M, Herrmann J, Tolle M, van der Giet M Xanthine oxidase and its role as target in cardiovascular disease: cardiovascular protection by enzyme inhibition?

Curr Pharm Des — MacIsaac RL, Salatzki J, Higgins P, Walters MR, Padmanabhan S, Dominiczak AF, Touyz RM, Dawson J Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension — Valko M, Morris H, Cronin MTD Metals, toxicity and oxidative stress.

Curr Top Med Chem — Atkinson MA, Warady BA Anemia in chronic kidney disease. Pediatr Nephrol:1— Locatelli F, Barany P, Covic A, De FA, Del VL, Goldsmith D, Horl W, London G, Vanholder R, Van BW Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement.

Baracco R, Saadeh S, Valentini R, Kapur G, Jain A, Mattoo TK Iron deficiency in children with early chronic kidney disease. Koshy SM, Geary DF Anemia in children with chronic kidney disease.

Dursun I, Poyrazoglu HM, Gunduz Z, Ulger H, Yýkýlmaz A, Dusunsel R, Patýroglu T, Gurgoze M The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease.

Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL, Lucas MF, Gomez-Coronado D, Ortuno J, Lasuncion MA Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects.

Am J Clin Nutr — Download references. DM is supported by the Clinical Research Fund of UZ Leuven, by the Fund for Scientific Research G0BN, and by a research grant from the European Society for Pediatric Nephrology.

FJ is a Fellow of the Fonds National de la Recherche Scientifique. Department of Microbiology and Immunology, Laboratory of Nephrology, KU Leuven — University of Leuven, , Leuven, Belgium. Department of Nephrology, Dialysis and Renal Transplantation, University Hospitals Leuven, , Leuven, Belgium.

Department of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden. Department of Pharmaceutical and Pharmacological Sciences, Pharmaceutical Analysis, KU Leuven — University of Leuven, , Leuven, Belgium. Department of Development and Regeneration, Laboratory of Pediatrics, PKD Group, KU Leuven — University of Leuven, , Leuven, Belgium.

Department of Pediatric Nephrology, University Hospitals Leuven, , Leuven, Belgium. Division of Nephrology, Department of Internal Medicine, University of Liège Hospital ULg CHU , Liège, Belgium. Groupe Interdisciplinaire de Génoprotéomique Appliquée GIGA , Cardiovascular Science, University of Liège, Liège, Belgium.

You can also search for this author in PubMed Google Scholar. Correspondence to Kristien Daenen. Reprints and permissions. Daenen, K. et al. Oxidative stress in chronic kidney disease.

Pediatr Nephrol 34 , — Download citation. Received : 21 December Revised : 03 June Accepted : 14 June Published : 13 August Issue Date : 01 June Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Access this article Log in via an institution. References Locatelli F, Canaud B, Eckardt K-U, Stenvinkel P, Wanner C, Zoccali C Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.

Nephrol Dial Transplant — Article CAS PubMed Google Scholar Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O Oxidative stress and antioxidant defense. World Allergy Organ J —19 Article CAS PubMed PubMed Central Google Scholar Di Meo S, Reed TT, Venditti P, Victor VM Role of ROS and RNS sources in physiological and pathological conditions.

Oxidative Med Cell Longev —44 Google Scholar Che R, Yuan Y, Huang S, Zhang A Mitochondrial dysfunction in the pathophysiology of renal diseases. AJP Ren Physiol F—F Article CAS Google Scholar Sureshbabu A, Ryter SW, Choi ME Oxidative stress and autophagy: crucial modulators of kidney injury.

Redox Biol — Article CAS PubMed PubMed Central Google Scholar Himmelfarb J Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin — Article PubMed Google Scholar Popolo A, Autore G, Pinto A, Marzocco S Oxidative stress in patients with cardiovascular disease and chronic renal failure.

Free Radic Res — Article CAS PubMed Google Scholar Sibal L, Agarwal SC, Home PD, Boger RH The role of asymmetric dimethylarginine ADMA in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev —90 Article CAS PubMed PubMed Central Google Scholar Yu M, Kim YJ, Kang DH Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress Clin J Am Soc Nephrol Ward RA, McLeish KR Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency.

J Am Soc Nephrol — CAS PubMed Google Scholar Tbahriti HF, Kaddous A, Bouchenak M, Mekki K Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients.

Biochem Res Int Article CAS PubMed PubMed Central Google Scholar Jankowska M, Rutkowski B, Dębska-Ślizień A Vitamins and microelement bioavailability in different stages of chronic kidney disease. Nutrients 9 Stocker R, Keaney JF Jr Role of oxidative modifications in atherosclerosis.

Med Pr — Article PubMed Google Scholar Birben E, Murat U, Md S, Sackesen C, Erzurum S, Kalayci O Oxidative stress and antioxidant defense.

WAO J —19 CAS Google Scholar Pieczenik SR, Neustadt J Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol —92 Article CAS PubMed Google Scholar Brandes RP, Kreuzer J Vascular NADPH oxidases: molecular mechanisms of activation.

Cardiovasc Res —27 Article CAS PubMed Google Scholar Lambeth JD Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Br J Pharmacol — Article CAS PubMed Google Scholar Chen F, Haigh S, Barman S, Fulton DJ From form to function: the role of Nox4 in the cardiovascular system.

Front Physiol CAS PubMed PubMed Central Google Scholar Cai H NAD P H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res — Article CAS PubMed Google Scholar Förstermann U, Li H Therapeutic effect of enhancing endothelial nitric oxide synthase eNOS expression and preventing eNOS uncoupling.

Br J Pharmacol — Article CAS PubMed PubMed Central Google Scholar Alp NJ, Channon KM Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol — Article CAS PubMed Google Scholar Yogalingam G, Lee AR, Mackenzie DS, Maures TJ, Rafalko A, Prill H, Berguig GY, Hague C, Christianson T, Bell SM, LeBowitz JH Cellular uptake and delivery of myeloperoxidase to lysosomes promote lipofuscin degradation and lysosomal stress in retinal cells.

J Biol Chem — Article CAS PubMed PubMed Central Google Scholar Ray RS, Katyal A Myeloperoxidase: bridging the gap in neurodegeneration. Neurosci Biobehav Rev — Article CAS PubMed Google Scholar Daugherty A, Dunn JL, Rateri DL, Heinecke JW Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

J Clin Invest — Article CAS PubMed PubMed Central Google Scholar Brennan ML, Penn MS, Van LF, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL Prognostic value of myeloperoxidase in patients with chest pain.

N Engl J Med — Article CAS PubMed Google Scholar Nicholls SJ, Tang WH, Brennan D, Brennan ML, Mann S, Nissen SE, Hazen SL Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.

Age Omaha — Article CAS Google Scholar Pham-Huy LA, He H, Pham-Huy C Free radicals, antioxidants in disease and health. Int J Biomed Sci —96 CAS PubMed PubMed Central Google Scholar Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK Ceruloplasmin and cardiovascular disease. Free Radic Biol Med — Article CAS PubMed Google Scholar Ehrenwald E, Fox PL Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U monocytic cells.

J Clin Invest — Article CAS PubMed PubMed Central Google Scholar Ehrenwald E, Chisolm GM, Fox PL Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest — Article CAS PubMed PubMed Central Google Scholar Alam J, Cook JL How many transcription factors does it take to turn on the heme oxygenase-1 gene?

Am J Respir Cell Mol Biol — Article CAS PubMed Google Scholar Kensler TW, Wakabayashi N, Biswal S Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Annu Rev Pharmacol Toxicol — Article CAS PubMed Google Scholar Lubos E, Loscalzo J, Handy DE Glutathione Peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal — Article CAS PubMed PubMed Central Google Scholar Shibahara S The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism.

Tohoku J Exp Med — Article CAS PubMed Google Scholar Gonzalez-Sanchez E, Perez MJ, Nytofte NS, Briz O, Monte MJ, Lozano E, Serrano MA, Marin JJG Protective role of biliverdin against bile acid-induced oxidative stress in liver cells.

Free Radic Biol Med — Article CAS PubMed Google Scholar Abraham NG, Kappas A Heme oxygenase and the cardiovascular-renal system.

Exaggerated oxidatlve stress OS is usually considered Metabolism boosting supplements a strews in regular oxidative stress and kidney health of strwss organism. Therefore, the OS-associated biomarkers may be considered as new kirney oxidative stress and kidney health of various diseases. In nephrology, researchers are looking for alternative methods replacing the renal biopsy in patients with suspicion of chronic kidney disease CKD. Currently, CKD is a frequent health problem in world population, which can lead to progressive loss of kidney function and eventually to end-stage renal disease. The course of CKD depends on the primary disease. Type the ans from the image. Please don't use dangerous characters. Title Author Abstract Keywords First Name Last Name. eISSN : Read This Article.